Instructions for Desloratadine pills
Release form
tab, film coating, 5 mg: 10 or 30 pcs
Pharmaco-therapeutic group:
Antiallergic agent histamine receptor blocker
Description:
The tablets, covered with a film shell of blue color, round, double-convex; two layers are visible on the cross section: A white or almost white kernel with a slightly pinkish tint and a blue shell; roughness of the surface of the tablets is allowed.
1 tab.
desloratadin 5 mg
Auxiliary substances: mannitol, cellulose microcrystalline, calcium hydrophosphate dihydrate, cornstarch pregelatinized, talc, magnesium stearate.
Shell Auxiliary Substances: VIVACOAT® [Hypromellose (HPMC) 6, titanium dioxide, polydextrose, talc, polyethylene glycol ( PEG ) 3350, indigotin (E 132)].
10 pcs - packages of box contour (1) - cardboard packs.
10 pcs - box-type contour (3) packages - cardboard packs.
ATC codes
R06AX27 Desloratadine
Clinical-pharmacological groups / Group affiliation
Histamine receptor blocker. Anti-allergy drug Desloratadine
Active substance
desloratadin
Testimony:
Seasonal allergic rhinitis, chronic idiopathic urticaria.
Method of use, course and dosage:
Adults and adolescents aged 12 years or older are given an oral dose of 5 mg/day regardless of ingestion.
Children aged 1 to 5 years 1.25 mg per day, 6 to 11 years 2.5 mg per day.
Application for kidney disorders
It is carefully prescribed Desloratadine for severe kidney failure.
Use in children
It is contraindicated in children under 2 years of age.
Nosology (ICD codes)
J30.1
Allergic rhinitis caused by plant pollen
L50
Urticaria
Drugs:
anti-inflammatory, antiallergic, antihistamine
